Skip to main content

Table 7 Multivariate regression analysis: impact of patient covariates and valve prosthesis on patient Late-term survival (median 24-month)

From: Sutureless Biological Aortic Valve Replacement (Su-AVR) in Redo operations: a retrospective real-world experience report of clinical and echocardiographic outcomes

 

Hazard ratio

Standard error

95% CI

P value

Age

1.1

0.047

0.976–1.172

0.149

T2DM

15.1

1.1

1.593–142.424

0.018

Smoking

0.1

1.5

0.005–1.361

0.080

COPD

1.1

1.5

0.057–21.364

0.948

Gender

7.5

1.6

0.325–175.942

0.207

HT

0.1

1.3

0.008–1.304

0.079

Perceval

3.2

1.3

0.264–41.189

0.354

NYHA

1.0

0.7

0.264–4.090

0.957